Trial intelligence / Profile preview

Angiotensin 1-7 for COVID-19 pneumonia

MOH_2020-11-02_009463Phase 2Not yet recruiting

Sponsor
דר' אתי קרוזל-דוילה
Start
Aug 2020
Modality
Peptides
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in coronavirus pneumonia comparing TXA127 treatment arm with Placebo arm (2 arms). Primary endpoints: Need for invasive mechanical ventilation and Mortality. Planned start Aug 2020; status: not yet recruiting.

02

Drugs

angiotensin-(1-7)
03

Conditions

coronavirus pneumonia

Beyond the preview

Go deeper on MOH_2020-11-02_009463.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on MOH_2020-11-02_009463.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call